Package 71511-503-30

Brand: nexiclon xr

Generic: clonidine
NDC Package

Package Facts

Identity

Package NDC 71511-503-30
Digits Only 7151150330
Product NDC 71511-503
Product ID 71511-503_dad34ef3-06d2-6355-e053-2995a90aee5f
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71511-503-30)

Marketing

Marketing Status
Marketed Since 2022-03-01
Brand nexiclon xr
Generic clonidine
Sample Package No

Linked Drug Pages (1)

Nexiclon XR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "dad34ef3-06d2-6355-e053-2995a90aee5f", "openfda": {"nui": ["N0000009918", "N0000175554"], "unii": ["MN3L5RMN02"], "rxcui": ["885880", "1050338"], "spl_set_id": ["dad35a6f-d57e-f302-e053-2995a90a9efb"], "pharm_class_epc": ["Central alpha-2 Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic alpha2-Agonists [MoA]"], "manufacturer_name": ["Athena Bioscience, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71511-503-30)", "package_ndc": "71511-503-30", "marketing_start_date": "20220301"}], "brand_name": "Nexiclon XR", "product_id": "71511-503_dad34ef3-06d2-6355-e053-2995a90aee5f", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "71511-503", "generic_name": "Clonidine", "labeler_name": "Athena Bioscience, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nexiclon XR", "active_ingredients": [{"name": "CLONIDINE", "strength": ".17 mg/1"}], "application_number": "NDA022500", "marketing_category": "NDA", "marketing_start_date": "20220301", "listing_expiration_date": "20261231"}